Questions? Feedback? powered by Olark live chat software
Cell Viability Assay, Cytotoxicity Assay, Cytopathic Effect Assay, CPE Assay, TCID50, Antiviral Drug Screening, Viral Toxicity Assay, Viral Titer Assay, g894
The Viral ToxGlo Assay is a simple, quantifiable method of determining viral-induced cytopathic effects (CPE) in host cells caused by lytic virions. The assay measures cellular ATP as a surrogate measure of host cell viability.
The Viral ToxGlo Assay is a simple, quantifiable method of determining viral-induced cytopathic effects (CPE) in host cells caused by lytic virions. The assay measures cellular ATP as a surrogate measure of host cell viability. When CPE occurs due to viral infection, ATP depletion can be measured and correlated with viral burden. The amount of ATP detected is directly proportional to the number of viable host cells in culture and can be used as a simple method to quantify viral-induced CPE. The homogeneous "add-mix-measure" assay procedure involves adding the single reagent (ATP Detection Reagent) directly to host cells following viral treatment. A

E: care@invitro.com.au
P: 1300 552 003